GLP-1 / GIP / GLUCAGON 15mg – 10 PACK

$1,599.99

GLP-1 / GIP / GLUCAGON 15mg – 10 PACK — a triple-receptor (GLP-1/GIP/glucagon) research peptide, supplied as lyophilised powder for in vitro and laboratory research. COA-verified purity; certificates of analysis are published on this site. Not for human consumption, clinical, or veterinary use.

Supplied for laboratory research use only. Orders are accepted from research institutions, licensed researchers, universities and laboratory R&D purchasers. Not for human or veterinary use.

Discount per Quantity

Quantity2 - 56 - 78 - 910 +
Discount5%10%15%25%
Price$1,519.99$1,439.99$1,359.99$1,199.99

Free Shipping over $200

Orders ship within 24 hours

Further reading

Reference articles on identity, analysis and Canadian research-use status. They describe how these materials are characterised, not how they are used.

Description

GLP-1 / GIP / GLUCAGON 15mg (x10 vials) – Research-Grade Triple Receptor Peptide

Delivery Time: 1–2 Weeks for 10 Packs

GLP-1 / GIP / GLUCAGON 15mg is a high-purity, research-grade peptide formulated for laboratory and analytical research purposes. As a triple receptor peptide targeting GLP-1, GIP, and glucagon pathways, GLP-1 / GIP / GLUCAGON is referenced in scientific literature for laboratory studies into receptor signaling, receptor signalling pathways, and intracellular hormone interactions.

This product is strictly intended for laboratory research use and is not approved for human consumption, veterinary use, clinical application, or therapeutic use.


What Is GLP-1 / GIP / GLUCAGON?

GLP-1 / GIP / GLUCAGON is a synthetic peptide designed for research into GLP-1, GIP, and glucagon receptor signaling. In laboratory environments, it is referenced for studies of:

• Receptor activation and intracellular signaling
• Receptor pathway modulation in controlled experiments
• Glucose and energy pathway research models
• Multi-receptor interactions in cellular assays

All uses are limited to in vitro, ex vivo, or analytical research, with no claims regarding effects in humans or animals.


Research Applications of GLP-1 / GIP / GLUCAGON

GLP-1 / GIP / GLUCAGON is suitable for controlled laboratory studies focusing on:

• GLP-1, GIP, and Glucagon Receptor Research – Investigating receptor-binding and signaling pathways
• Receptor signalling Pathway Modeling – Laboratory exploration of intracellular receptor signalling
• Multi-Pathway Receptor Studies – Evaluating combined receptor interactions in cellular models
• Analytical and Biochemical Research – For peptide characterization, dose-response experiments, and signaling pathway investigations
• Extended Laboratory Protocols – Ideal for multi-dose or batch studies requiring consistent peptide supply

All applications are research-focused; this product is not for human or veterinary use.


Product Specifications

• Peptide: GLP-1 / GIP / GLUCAGON
• Quantity: 15mg per vial × 10 vials
• Grade: Research-Grade
• Intended Use: Laboratory research only
• Storage: Follow standard peptide storage and laboratory handling protocols

The 10-vial pack provides flexibility for extended experiments and multi-phase research protocols.


Purity & Quality Assurance

ExoLabz peptides undergo rigorous quality control and third-party testing to verify purity, identity, and consistency. Each GLP-1 / GIP / GLUCAGON 15mg batch has a verified COA.

Researchers may perform independent testing. If verified results do not meet stated specifications, ExoLabz provides a refund and testing reimbursement.


Important Legal Disclaimer

For Research Purposes Only
GLP-1 / GIP / GLUCAGON 15mg is intended strictly for laboratory research and scientific investigation. It is not approved by Health Canada, FDA, or any other regulatory authority. This product is not for human consumption, clinical use, or therapeutic application. By purchasing, you confirm it will be used exclusively for lawful laboratory research purposes.

Research Literature

Peer-reviewed studies involving this compound and its class. All findings listed are from in vitro, cell culture or animal models and are provided for scientific reference only. This product is supplied for laboratory research and is not approved for human consumption, clinical, or veterinary use.

  • Willard FS, et al. JCI Insight. 2020;5(17):e140532. In HEK293 and CHO-K1 cells, measured competition radioligand binding, cAMP accumulation, beta-arrestin recruitment and receptor internalisation at human GIPR and GLP-1R. Source · PMID 32730231
  • Zhao F, et al. Nat Commun. 2022;13:1057. Solved five cryo-EM structures of Gs-coupled GIPR, GLP-1R and GCGR at 3.0-3.5 A and measured cAMP potency across site-directed receptor mutants. Source · PMID 35217653
  • Knerr PJ, et al. Mol Metab. 2022;63:101533. Rodent study comparing triagonists with tuned GLP-1R/GIPR/GCGR potency ratios; see the linked record for methods and endpoints. Source · PMID 35809773

Literature notes: References concern receptor pharmacology and preclinical models. Clinical literature is outside the scope of this list.

Browse more compounds in Incretin & Glucagon Peptides, or view the full research peptide catalogue.

Additional information

Weight0.01 kg
Dimensions4.5 × 1.6 × 4.5 cm